{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:53:39Z","timestamp":1791125619027,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of transplantation in infants with acute lymphoblastic leukemia (ALL) is not defined. We analyzed results of 40 infants diagnosed before age 12 months who received a hematopoietic cell transplant (HCT) between July 1982 and February 2003 in first complete remission (CR1; n = 17), CR2\/3 (n = 7), or relapse (n = 16). Patients were conditioned with cyclophosphamide with total body irradiation (n = 39) or busulfan (n = 1). Donors were matched related (n = 8), mismatched related (n = 16), or unrelated (n = 16). Graft-versus-host disease (GVHD) prophylaxis was methotrexate or cyclosporine (n = 7) or methotrexate plus cyclosporine (n = 33). Thirty-nine patients engrafted, 20 developed acute GVHD, and 7 developed chronic GVHD. Sixteen patients relapsed and 7 died of other causes. Patients in CR1 had disease-free survival (DFS) of 76% compared with 45% for CR2\/CR3 and 8% for relapse (P &amp;lt; .001). Of 33 patients with cytogenetic data, 26 (79%) had MLL gene rearrangement. Fourteen of these 26 were in CR1 and 11 survive in remission. Outcome was associated with phase of disease, but having the MLL gene was not a factor predictive of outcome. Late effects included growth and other hormone deficiencies. These data demonstrate that infants with ALL and MLL gene have excellent DFS when they received transplants in CR1, and consideration for transplantation in CR1 is warranted.<\/jats:p>","DOI":"10.1182\/blood-2004-08-3312","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T03:38:42Z","timestamp":1105069122000},"page":"3749-3756","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":79,"title":["Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"105","author":[{"given":"Jean E.","family":"Sanders","sequence":"first","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Joon","family":"Im","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Hoffmeister","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"Gooley","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Woolfrey","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Andrews","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Bryant","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"From the Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; the Department of Pediatrics, University of Washington School of Medicine, Seattle; the Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; the Department of Biostatistics, University of Washington School of Public Health and Community Medicine, Seattle; and the Department of Medicine, University of Washington School of Medicine, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223155433000_REF1","doi-asserted-by":"crossref","unstructured":"Reaman G, Zeltzer P, Bleyer WA, et al. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. J Clin Oncol. 1985;3: 1513-1521.","DOI":"10.1200\/JCO.1985.3.11.1513"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Biondi A, Cimino G, Pieters R, Pui C-H. Biological and therapeutic aspects of infant leukemia. Blood. 2000;96: 24-33.","DOI":"10.1182\/blood.V96.1.24"},{"key":"2020021223155433000_REF3","unstructured":"Chessells JM, Eden OB, Bailey CC, Lilleyman JS, Richards SM. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia. 1994;8: 1275-1279."},{"key":"2020021223155433000_REF4","doi-asserted-by":"crossref","unstructured":"Felix CA, Lange BJ. Leukemia in infants. Oncologist. 1999;4: 225-240.","DOI":"10.1634\/theoncologist.4-3-225"},{"key":"2020021223155433000_REF5","doi-asserted-by":"crossref","unstructured":"Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993;81: 2386-2393.","DOI":"10.1182\/blood.V81.9.2386.2386"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Pui CH, Behm FG, Downing JR, et al. 11q23\/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol. 1994;12: 909-915.","DOI":"10.1200\/JCO.1994.12.5.909"},{"key":"2020021223155433000_REF7","doi-asserted-by":"crossref","unstructured":"Hilden JM, Frestedt JL, Moore RO, et al. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23). Blood. 1995;86: 3876-3882.","DOI":"10.1182\/blood.V86.10.3876.bloodjournal86103876"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Heerema NA, Sather HN, Ge J, et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11): a report of the Children's Cancer Group. Leukemia. 1999;13: 679-686.","DOI":"10.1038\/sj.leu.2401413"},{"key":"2020021223155433000_REF9","doi-asserted-by":"crossref","unstructured":"Pui C-H, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 2002;359: 1909-1915.","DOI":"10.1016\/S0140-6736(02)08782-2"},{"key":"2020021223155433000_REF10","doi-asserted-by":"crossref","unstructured":"Frankel LS, Ochs J, Shuster JJ, et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J Pediatr Hematol Oncol. 1997;19: 35-42.","DOI":"10.1097\/00043426-199701000-00005"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Silverman LB, McLean TW, Gelber RD, et al. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer. 1997;80: 2285-2295.","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2285::AID-CNCR10>3.0.CO;2-Q"},{"key":"2020021223155433000_REF12","doi-asserted-by":"crossref","unstructured":"Reaman GH, Sposto R, Sensel MG, et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol. 1999;17: 445-455.","DOI":"10.1200\/JCO.1999.17.2.445"},{"key":"2020021223155433000_REF13","doi-asserted-by":"crossref","unstructured":"Copelan EA, Kapoor N, Murcek M, Theil K, Tutschka PJ. Marrow transplantation following busulfan and cyclophosphamide as treatment for translocation (4;11) acute leukaemia. Br J Haematol. 1988;70: 127-128.","DOI":"10.1111\/j.1365-2141.1988.tb02447.x"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Bordigoni P, Benz-Lemoine E, Vannier JP, Fischer A. Bone marrow transplantation following busulfan, cyclophosphamide and high dose cytosine-arabinoside as treatment for infants with translocation (4;11) acute leukaemia. Br J Haematol. 1989;72: 293-294.","DOI":"10.1111\/j.1365-2141.1989.tb07702.x"},{"key":"2020021223155433000_","unstructured":"Emminger W, Emminger-Schmidmeier W, Haas OA, et al. Treatment of infant leukemia with busulfan, cyclophosphamide + etoposide and bone marrow transplantation. Bone Marrow Transplant. 1992;9: 313-318."},{"key":"2020021223155433000_REF16","unstructured":"von Bueltzingsloewen A, Esperou-Bourdeau H, Souillet G, et al. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Socie\u0301te\u0301 Franc\u0327aise de Greffe de Moelle. Bone Marrow Transplant. 1995;16: 521-527."},{"key":"2020021223155433000_REF17","doi-asserted-by":"crossref","unstructured":"Pirich L, Haut P, Morgan E, Marymount M, Kletzel M. Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphocytic leukemia. Med Pediatr Oncol. 1999;32: 1-6.","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<1::AID-MPO2>3.0.CO;2-J"},{"key":"2020021223155433000_REF18","doi-asserted-by":"crossref","unstructured":"Marco F, Bureo E, Ortega JJ, et al. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support. Groupo Espanol de Trasplante de Medula Osea en Ninos. J Clin Oncol. 2000;18: 3256-3261.","DOI":"10.1200\/JCO.2000.18.18.3256"},{"key":"2020021223155433000_REF19","doi-asserted-by":"crossref","unstructured":"Leung W, Pitts N, Burnette K, et al. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome. Bone Marrow Transplant. 2001;27: 717-722.","DOI":"10.1038\/sj.bmt.1702998"},{"key":"2020021223155433000_REF20","doi-asserted-by":"crossref","unstructured":"Ayas M, Belgaumi A, Al-Mahr M, Al-Jefri A, Solh H. Allogeneic BMT for infantile acute leukemia: what is the optimal conditioning regimen? [letter]. Bone Marrow Transplant. 2002;29: 630.","DOI":"10.1038\/sj.bmt.1703420"},{"key":"2020021223155433000_REF21","doi-asserted-by":"crossref","unstructured":"Pui C-H, Chessells JM, Camitta B, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia. 2003;17: 700-706.","DOI":"10.1038\/sj.leu.2402883"},{"key":"2020021223155433000_REF22","doi-asserted-by":"crossref","unstructured":"Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood. 2002;99: 2002-2008.","DOI":"10.1182\/blood.V99.6.2002"},{"key":"2020021223155433000_REF23","unstructured":"Hansen JA, Mickelson EM, Choo SY, et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose NR, De Macario EC, Fahey JL, Friedman H, Penn GM, eds. Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology; 1992: 850-866."},{"key":"2020021223155433000_REF24","doi-asserted-by":"crossref","unstructured":"Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics. 1991;33: 267-275.","DOI":"10.1007\/BF00230505"},{"key":"2020021223155433000_REF25","doi-asserted-by":"crossref","unstructured":"Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320: 197-204.","DOI":"10.1056\/NEJM198901263200401"},{"key":"2020021223155433000_REF26","doi-asserted-by":"crossref","unstructured":"Thompson CB, Sanders JE, Flournoy N, Buckner CD, Thomas ED. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood. 1986;67: 195-199.","DOI":"10.1182\/blood.V67.1.195.195"},{"key":"2020021223155433000_REF27","unstructured":"Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med. 1975;292: 832-843, 895-902."},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344: 175-181.","DOI":"10.1056\/NEJM200101183440303"},{"key":"2020021223155433000_REF29","unstructured":"Broxmeyer HE, Kurtzberg J, Gluckman E, et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells. 1991;17: 313-329."},{"key":"2020021223155433000_REF30","doi-asserted-by":"crossref","unstructured":"Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med. 1992;326: 845-851.","DOI":"10.1056\/NEJM199203263261301"},{"key":"2020021223155433000_REF31","doi-asserted-by":"crossref","unstructured":"Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med. 1993;118: 173-178.","DOI":"10.7326\/0003-4819-118-3-199302010-00003"},{"key":"2020021223155433000_REF32","doi-asserted-by":"crossref","unstructured":"Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood. 1996;88: 4063-4071.","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063"},{"key":"2020021223155433000_REF33","doi-asserted-by":"crossref","unstructured":"Durnam DM, Anders KR, Fisher L, O'Quigley JO, Bryant EM, Thomas ED. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood. 1989;74: 2220-2226.","DOI":"10.1182\/blood.V74.6.2220.2220"},{"key":"2020021223155433000_REF34","doi-asserted-by":"crossref","unstructured":"Ugozzoli L, Yam P, Petz LD, et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood. 1991;77: 1607-1615.","DOI":"10.1182\/blood.V77.7.1607.1607"},{"key":"2020021223155433000_REF35","doi-asserted-by":"crossref","unstructured":"Storb R, Deeg HJ, Pepe M, et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood. 1989;73: 1729-1734.","DOI":"10.1182\/blood.V73.6.1729.1729"},{"key":"2020021223155433000_REF36","doi-asserted-by":"crossref","unstructured":"Doney KC, Weiden PL, Storb R, Thomas ED. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol. 1981;11: 1-8.","DOI":"10.1002\/ajh.2830110102"},{"key":"2020021223155433000_REF37","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57: 267-276.","DOI":"10.1182\/blood.V57.2.267.267"},{"key":"2020021223155433000_REF38","doi-asserted-by":"crossref","unstructured":"Wechsler D. Wechsler Preschool and Primary Intelligence Scales for Children-Revised. New York: The Psychology Corporation; 1989.","DOI":"10.1037\/t48859-000"},{"key":"2020021223155433000_REF39","unstructured":"Wechsler D. Intelligence Scale for Children, Revised. New York: The Psychological Corporation; 1974."},{"key":"2020021223155433000_REF40","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"2020021223155433000_REF41","doi-asserted-by":"crossref","unstructured":"Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol. 1993;83: 602-607.","DOI":"10.1111\/j.1365-2141.1993.tb04697.x"},{"key":"2020021223155433000_REF42","doi-asserted-by":"crossref","unstructured":"Chessells JM, Harrison CJ, Kempski H, et al. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia. 2002;16: 776-784.","DOI":"10.1038\/sj.leu.2402468"},{"key":"2020021223155433000_","doi-asserted-by":"crossref","unstructured":"Ferster A, Benoit Y, Francotte N, et al. Treatment outcome in infant acute lymphoblastic leukemia [letter]. Blood. 2000;95: 2729-2731.","DOI":"10.1182\/blood.V95.8.2729"},{"key":"2020021223155433000_REF44","doi-asserted-by":"crossref","unstructured":"Borkhardt A, Wuchter C, Viehmann S, et al. Infant acute lymphoblastic leukemia\u2014combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia. 2002;16: 1685-1690.","DOI":"10.1038\/sj.leu.2402595"},{"key":"2020021223155433000_REF45","doi-asserted-by":"crossref","unstructured":"Kosaka Y, Koh K, Kinukawa N, et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood. 2004;104: 3527-3534.","DOI":"10.1182\/blood-2004-04-1390"},{"key":"2020021223155433000_REF46","doi-asserted-by":"crossref","unstructured":"Leung W, Hudson M, Zhu Y, et al. Late effects in survivors of infant leukemia. Leukemia. 2000;14: 1185-1190.","DOI":"10.1038\/sj.leu.2401818"},{"key":"2020021223155433000_REF47","doi-asserted-by":"crossref","unstructured":"Sanders JE. Growth and development after hematopoietic cell transplantation. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, United Kingdom: Blackwell Publishing Ltd; 2004: 929-943.","DOI":"10.1002\/9780470987070.ch68"},{"key":"2020021223155433000_REF48","doi-asserted-by":"crossref","unstructured":"Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol. 2004;26: 81-90.","DOI":"10.1097\/00043426-200402000-00003"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3749\/1710191\/zh800905003749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/9\/3749\/1710191\/zh800905003749.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T07:03:48Z","timestamp":1586070228000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/9\/3749\/21277\/Allogeneic-hematopoietic-cell-transplantation-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-08-3312","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}